If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,026.00    20.00 (1.99%)
Bid:
1,026.00
Ask:
1,030.00
Spread: 4.00 (0.39%)
Market Cap: £147.01b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Invitation to purchase certain instruments

13 Feb 2025 12:00

RNS Number : 0545X
Banco Santander S.A.
13 February 2025
 

Banco Santander, S.A., ("Santander" or the "Offeror") in accordance with the provisions of the securities market legislation, communicates the following:

OTHER RELEVANT INFORMATION

Further to the communication made on 6 February 2025 (registered under number 2585) regarding the invitation by Santander to holders of its outstanding €1,500,000,000 3.250 per cent. Subordinated Instruments due April 2026 (ISIN: XS1384064587) (the "EUR 2026 Notes") and €1,000,000,000 3.125 per cent. Subordinated Instruments due January 2027 (ISIN: XS1548444816) (the "EUR 2027 Notes" and, together with the EUR 2026 Notes, the "Notes" and each a "Series") to tender any and all of such Notes for purchase by the Offeror for cash, in accordance with the terms of the tender offer memorandum dated 6 February 2025 (the "Tender Offer Memorandum") (the "Offers"), the Offeror now announces the results of the Offers.

Capitalised terms used but not otherwise defined in this announcement shall have the meaning given to them in the Tender Offer Memorandum.

The Expiration Time for the Offers was 5.00 p.m. (CET) on 12 February 2025.

The Offeror hereby announces that it will accept for purchase in accordance with the terms and subject to the conditions set out in the Tender Offer Memorandum and at the relevant Purchase Price: (i) €600,800,000 in aggregate principal amount of the EUR 2026 Notes; and (ii) €563,600,000 in aggregate principal amount of the EUR 2027 Notes, as set out in the table below.

 

Description of Notes

ISIN

Maturity Date

Aggregate principal amount accepted

Reference Benchmark

Reference Benchmark Yield

Purchase Spread

Purchase Yield

Purchase Price (expressed as a percentage)

€1,500,000,000 3.250 per cent. Subordinated Instruments due April 2026

XS1384064587

4 April 2026

€600,800,000

EUR 2026 Interpolated Mid-Swap Rate

2.356%

+25 bps.

 

2.606%

100.701%

€1,000,000,000 3.125 per cent. Subordinated Instruments due January 2026

XS1548444816

19 January 2027

€563,600,000

EUR 2027 Interpolated Mid-Swap Rate

2.284%

+35 bps.

 

2.634%

100.905%

Notes purchased by the Offeror pursuant to the Offer will be cancelled by the Offeror and will not be re-issued or re-sold. Notes which have not been validly submitted or validly submitted but not accepted for purchase pursuant to the Offer will remain outstanding. Following the Settlement Date, there will be an outstanding nominal amount of (i) €899,200,000 of EUR 2026 Notes and (ii) €463,400,000 of EUR 2027 Notes.

Payment of the relevant Tender Consideration in respect of the Notes accepted for purchase by the Offeror will occur on the Settlement Date, which is expected to be 17 February 2025.

Any requests for information in relation to the Offers should be directed to the Dealer Managers or the Tender Agent whose contact details are listed below.

SOLE DEALER MANAGER

Santander Corporate and Investment Banking Ciudad Grupo SantanderAvenida de Cantabria s/n28660Madrid, SpainAttn: Liability ManagementEmail: liabilitymanagement@gruposantander.com

 

THE TENDER AGENTKroll Issuer Services Limited The Shard32 London Bridge StreetLondon SE1 9SGUnited KingdomTel: +44 20 7704 0880 Attn: David Shilson/Scott BoswellEmail: santander@is.kroll.comWebsite: https://deals.is.kroll.com/santander

 

 

Boadilla del Monte (Madrid), 13 February 2025

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE OR TO WHOM IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

 

 

DISCLAIMER

This announcement must be read in conjunction with the Tender Offer Memorandum. This announcement and the Tender Offer Memorandum contain important information which should be read carefully before any decision is made with respect to the Offer. If any Qualifying Holder is in any doubt as to the contents of this announcement, the Tender Offer Memorandum or the action it should take, it is recommended to seek its own financial, legal, regulatory and tax advice, including in respect of any tax consequences, immediately from its broker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser.

The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Offeror, the Sole Dealer Manager and the Tender Agent to inform themselves about, and to observe, any such restrictions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURPKNBPDBKDOBD
Date   Source Headline
22nd Oct 202511:11 amRNSThird Quarter 2025 Results Notice
16th Oct 202511:12 amRNSBuyback programme: transactions 9-15Oct
9th Oct 202511:05 amRNSBuyback programme: transactions 2-8Oct
3rd Oct 20252:58 pmRNSMoody's has upgraded Santanders rating
2nd Oct 20255:15 pmRNSDirector/PDMR Shareholding
2nd Oct 202511:07 amRNSBuyback programme: Transactions 25Sept-1Oct
30th Sep 20252:23 pmRNSDividend approval
30th Sep 202511:56 amRNSTotal Voting Rights
25th Sep 202511:12 amRNSBuyback programme: transactions 18-24Sept
18th Sep 202511:04 amRNSBuyback programme: transactions 11-17Sept
11th Sep 20254:54 pmRNSDirector/PDMR Shareholding
11th Sep 202511:07 amRNSBuyback programme: transactions 4-10Sept
4th Sep 202511:04 amRNSBuyback programme: transactions 28Aug-3Sept
29th Aug 20254:35 pmRNSTotal Voting Rights
29th Aug 202511:34 amRNSModification of internationalization covered bonds
28th Aug 202511:04 amRNSBuyback programme: transactions 21-27Aug
21st Aug 202511:04 amRNSBuyback programme: transactions 14-20Aug
14th Aug 202511:08 amRNSBuyback programme: transactions 7-13Aug
11th Aug 202511:09 amRNSDirector/PDMR Shareholding
7th Aug 202511:09 amRNSBuyback programme: transactions 31Jul - 6Aug
1st Aug 20255:48 pmRNSStress test Results
31st Jul 20254:57 pmRNSTotal Voting Rights
31st Jul 202512:07 pmRNSHalf-year Report
30th Jul 20257:00 amRNS1st Half 25 results report & earnings presentation
30th Jul 20257:00 amRNSFirst Half 2025 Results - Press release
30th Jul 20257:00 amRNSCommencement of a program to repurchase own shares
23rd Jul 202511:11 amRNSNotice of First Half 2025 Results
2nd Jul 20257:00 amRNSPresentation to analysts about transaction on TSB
1st Jul 20256:20 pmRNSSantander to acquire TSB. Analysts meeting notice
1st Jul 20252:55 pmRNSInvitation to buy outstanding preferred securities
30th Jun 202511:55 amRNSTotal Voting Rights
27th Jun 20254:49 pmRNSDirector/PDMR Shareholding
27th Jun 20254:47 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSInvitation to buy outstanding preferred securities
24th Jun 20257:48 amRNSInvitation to buy outstanding preferred securities
20th Jun 20255:16 pmRNSDirector/PDMR Shareholding
10th Jun 20253:54 pmRNSFurther re Capital reduction
10th Jun 20253:36 pmRNSDirector/PDMR Shareholding
3rd Jun 20252:38 pmRNSTotal Voting Rights
3rd Jun 202510:00 amRNSCapital reduction following completion of program
2nd Jun 202512:08 pmRNSTotal Voting Rights
29th May 202511:12 amRNSBuyback programme: transactions 22-28May
22nd May 202511:05 amRNSBuyback programme: transactions 14-21May
21st May 202512:41 pmRNSDirector/PDMR Shareholding
20th May 202512:57 pmRNSDirector/PDMR Shareholding
14th May 20255:36 pmRNSDirector/PDMR Shareholding
14th May 20253:33 pmRNSBuyback programme: transactions 7-13May
13th May 20254:11 pmRNSDirector/PDMR Shareholding
9th May 20251:17 pmRNSDirector/PDMR Shareholding
9th May 20251:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.